BGIM
DSCI

Brandywine Global Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Brandywine Global Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,910
Closed -$73K – 1017
2016
Q4 		$73K Buy
13,910
+6,510
+88% +$30.6K ﹤0.01% 805
2016
Q3 		$35K Buy
+7,400
New +$34.5K ﹤0.01% 820

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Brandywine Global Investment Management's DSCI Position: Q1 2017 in Review

Brandywine Global Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 13,910 shares — an estimated $73K sold.

Brandywine Global Investment Management first reported a position in DSCI in Q3 2016 and held it in 2 quarters. The position peaked at $73K in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Brandywine Global Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Brandywine Global Investment Management sold 13,910 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $73K.
  • Brandywine Global Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2016 and held it in 2 quarters.
  • Brandywine Global Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $73K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Brandywine Global Investment Management's 13F filing for Q1 2017, filed 15 May 2017.